Effects of CPAP treatment on 6MWD in OSAS and overlap syndrome patients Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002
CPAP and measures of cardiovascular risks in patients with OSAS Source: Eur Respir J 2009; 33: 1520 Year: 2009
Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004
The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018
Long term effects of CPAP therapy in sleep apnea patients with metabolic syndrome Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
The reversibility of hypoxemia in OSA patients is related to CPAP therapy Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005
Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
Long-term nCPAP compliance in patients with OSAS with initial in-hospital adjustment of nCPAP Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002
Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Determinants of CPAP compliance in bariatric patients with obstructive sleep apnoea Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017
CPAP setting prediction in OSAS patients Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea Year: 2011
Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002
Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea Year: 2006
Utility of a nurse-led visit program for patients with obstructive sleep apnea syndrome treated with CPAP Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012
Effects of CPAP treatment in UARS patients comparing to OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Effect of ventilation therapy on mortality rate among obesity hypoventilation syndrome and obstructive sleep apnoea patients Source: ERJ Open Res, 6 (2) 00101-2019; 10.1183/23120541.00101-2019 Year: 2020
Health related quality of life after CPAP treatment in patients with obstructive sleep apnoea and patients with overlap syndrome Source: Eur Respir J 2003; 22: Suppl. 45, 468s Year: 2003
Obesity hypoventilation syndrome: efficacy and predictive failure factors for CPAP treatment Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008
Effect of CPAP adherence on depression in OSA patient Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020
Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 320s Year: 2007